The Imperative of Valuing Patents for Innovation and Growth

Not every patent is worth keeping. That might sound counterintuitive, but it is one of the most important realities in intellectual property management. Companies file patents with genuine optimism – an invention looks promising, a technology seems ahead of its time. But commercial reality does not always follow technical brilliance. With IP budgets under constant pressure and annual renewal fees accumulating across a portfolio, managers face a recurring question: which patents are actually worth maintaining, and which should simply be let go? The answer lies in patent valuation – a discipline that is far more than an accounting exercise.

Not every innovation is a profitable asset 🔗

Filing a patent costs money. Renewing it year after year costs more. Managing a patent portfolio involves ongoing decisions about which patents to maintain and which to abandon, and without a clear sense of each patent’s worth, companies default to a dangerous inertia – paying to keep patents alive simply because they exist. This is where valuation steps in. IP valuation is the process of determining the monetary value of IP assets, and understanding it helps businesses distinguish between patents that contribute to revenue and competitive advantage, and those that merely consume budget.

The value of a patent is emphatically not the same as its cost of creation. As practitioners in the field note, the value of a patent, regardless of what it cost to develop, could be anywhere from zero to millions of dollars. Two patents from the same R&D lab, filed in the same year, can have wildly different commercial worth depending on market demand, technological relevance, and enforceability. Treating them as equivalent simply because their filing fees were equal is a strategic error.

Why patent valuation matters for management decisions 🔗

IP managers regularly confront renewal deadlines. In India, patents must be renewed annually after grant, and missing a deadline – even with a grace period – can result in the patent lapsing entirely. Under Section 60 of the Indian Patents Act, 1970, a lapsed patent may be restored within 18 months, but restoration is expensive, time-consuming, and not guaranteed. The smarter approach is to make an informed renewal decision in the first place – and that requires knowing what a patent is worth before the fee falls due.

For portfolio managers, a practical renewal framework applies a simple logic: keep patents covering critical technologies and active licensing deals, review borderline or overlapping assets, and drop outdated inventions or non-core markets. Each of these calls depends on valuation. Without a structured assessment of current and potential value, such decisions are made on intuition rather than analysis – and intuition is a poor basis for IP strategy.

Allocating limited IP budgets effectively 🔗

With limited resources and bottom-line pressures, companies need a high rate of return on their IP investments and appropriate protection for each asset. A company holding fifty patents cannot afford to treat all of them equally. Some protect core products, some have licensing potential, and some are functionally obsolete. Valuation provides the analytical foundation to prioritise renewal spending toward assets that generate or protect real value, while systematically phasing out patents that no longer serve business objectives. Strategic abandonment of patents covering outdated or non-core technologies is a deliberate cost-saving tool used by major corporations like Samsung, IBM, and Fujifilm.

The real value of a patent: exclusivity and future returns 🔗

So where does patent value actually come from? At its core, the value of an IP asset comes from the right it gives its owner to exclude competitors from using it. That exclusivity, when it covers something the market genuinely wants, creates the conditions for extraordinary returns. A patent on a drug formulation, a manufacturing process, or a platform technology can generate revenue streams far exceeding anything its R&D cost could suggest.

Exclusivity is a key determinant of IP value – the more exclusive the IP, the more valuable it tends to be. A patented technology that prevents competitors from entering a market creates pricing power, attracts investors, and forms the basis for licensing negotiations. This is why exclusivity is not merely a legal concept in patent law – it is an economic one, central to how valuators assess what a patent is actually worth.

Licensing: converting rights into revenue 🔗

One of the most direct ways a patent generates value is through licensing. Licensing royalties can be a significant profit driver, as they are often generated at minimal cost to the asset holder. Rather than manufacturing or selling anything themselves, the patent owner simply grants a third party the right to use the invention in exchange for periodic royalty payments. For companies with strong IP portfolios but limited manufacturing capacity, licensing can turn a patent into a steady income stream with relatively low overhead.

The valuation of a patent directly shapes the terms of these licensing negotiations. Knowing the value of IP rights is essential not only to reach a licensing agreement, but also to ensure both parties are engaging in a good deal. An overvalued patent leads to failed negotiations; an undervalued one leaves money on the table. Proper valuation sets the floor for royalty rates and informs whether an exclusive or non-exclusive licensing model makes commercial sense.

Cross-licensing: trading rights for access 🔗

Not all patent value is realised through direct royalty income. In industries where technologies overlap and innovation is fast-moving, cross-licensing is an equally important commercial tool. Cross-licensing allows two or more parties to exchange rights to their respective patents, avoiding costly litigation while each side gains access to the other’s technology. The AMD-Intel arrangement in microprocessors is a well-known example – decades of cross-licensing kept both companies operating without the mutual devastation of prolonged infringement suits.

In the Indian context, cross-licensing has growing relevance. In the pharmaceutical sector, a company with a breakthrough drug formulation may lack the delivery technology patented by another firm, making a cross-licensing arrangement practically necessary. Similarly, in the technology sector, hardware and software patents often need to be combined for a complete product. In both cases, the strength of the cross-licensing deal depends on how well each party has valued its own patents – a company that does not know its IP’s worth cannot negotiate a fair exchange.

Enforcing patent rights: valuation as a litigation tool 🔗

When infringement occurs, a patent holder’s options – sue, negotiate, or ignore – depend heavily on whether the patent has quantified value. IP valuation may be necessary at multiple stages of a dispute – it helps a party decide whether to engage in litigation at all, and then forms the basis for calculating damages if litigation proceeds. Filing a patent infringement suit in India or any jurisdiction involves significant cost and time. Only patents with demonstrable economic value justify that investment.

An offensive patent strategy – aggressively enforcing rights to gain competitive advantage – is particularly effective for patents covering proprietary technology developed in-house. But enforcement is a business decision, not just a legal one. Valuating a patent before pursuing infringement action ensures that the expected recovery is proportionate to the cost and risk of litigation. Where it is not, the strategic choice may instead be to compel infringers into a licensing arrangement, converting what would be a courtroom battle into a revenue opportunity.

Patent valuation and financial strategy 🔗

Beyond day-to-day IP management, patent valuation feeds into broader financial decisions. IP assets may be used to secure debt financing by pledging them as collateral, or a stable royalty stream may be securitised in exchange for immediate financing. For startups and innovation-driven companies in India, this can be transformative – converting intangible rights into working capital without diluting equity.

A strong patent portfolio is instrumental for fundraising, leverage in business transactions, exit strategy for startups, and mergers and acquisitions. Investors and venture capitalists, before committing capital, need to know what a company’s IP is worth. A well-valued portfolio signals both the robustness of the underlying technology and the management team’s sophistication in handling intangible assets. Conversely, a portfolio with no valuation framework signals uncertainty – and uncertainty increases the cost of capital.

For publicly traded companies, the stakes are even higher. Regulatory bodies often require accurate reporting of intangible assets, providing shareholders and stakeholders transparency about a company’s true worth beyond its physical assets. In an economy where expenditures on knowledge, through R&D and software, have grown faster than expenditures on tangible assets, the ability to accurately value patents is no longer a specialist skill – it is a core management competency.

The cost of not knowing 🔗

Perhaps the strongest argument for patent valuation is the cost of ignoring it. Companies that do not value their patents end up paying renewals on dead assets, leaving licensing revenue unclaimed, negotiating cross-licensing deals from positions of weakness, and entering or avoiding litigation based on instinct rather than data. Many organisations fail to understand the value of and the risks to their IP, even when that IP accounts for a high percentage of the company’s overall value. This is not a harmless oversight – it translates directly into lost competitive advantage and misallocated capital.

The imperative to value patents is ultimately an imperative to treat innovation as a managed asset rather than an archived achievement. A patent filed and forgotten is not an asset – it is a cost. A patent understood, valued, and strategically deployed is something else entirely: a lever for market dominance, commercial collaboration, and long-term financial strength.

What do you think? If a company holds fifty patents but has never formally valued any of them, how should it prioritise which ones to assess first? And should patent valuation be a standalone function within IP management, or should it be integrated directly into a company’s financial planning cycle?

References

1. https://patentpc.com/blog/patent-renewal-strategy-saving-costs-by-dropping-low-value-ip
2. https://www.wipo.int/en/web/business/ip-valuation
3. https://ipwatchdog.com/2017/07/12/patent-portfolio-valuations/
4. https://patentfilingcost.com/patent-renewal-in-india-your-complete-guide-to-keeping-your-innovation-protected/
5. https://ipnote.pro/en/blog/the-go-to-guide-to-patent-renewals/
6. https://www.marsh.com/en/services/property-risk-management/insights/importance-of-intellectual-property.html
7. https://www.intepat.com/blog/patent-management-strategies
8. https://www.dilworthip.com/resources/news/ip-valuation-most-important-asset/
9. https://www.heerlaw.com/determining-value-intellectual-property
10. https://depenning.com/blog/cross-licensing-agreements-a-strategic-tool-to-minimise-patent-conflicts/
11. https://ssrana.in/articles/patent-licensing-strategies-effective-ip-commercialization/
12. https://etonvs.com/valuation/intellectual-property-valuation/
13. https://en.wikipedia.org/wiki/Patent_valuation